Disposition of captopril in normal subjects

作者：Kishin J. Kripalani, Doris N. McKinstry, Sampat M. Singhvi, David A Willard, Robert A. Vukovich, Bruce H. Migdalof · 发表于：Clinical Pharmacology & Therapeutics · 年份：1980 · DOI：10.1038/clpt.1980.90 · 被引用次数：159 · 研究领域：Pharmacogenetics and Drug Metabolism、Hormonal Regulation and Hypertension、Pharmacological Effects and Toxicity Studies

The disposition of captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was studied in 10 normal male subjects after a single 100-mg tablet of 35S-labeled drug. Average absorption parameters for unchanged captopril in blood were Tmax 0.93 +/- 0.08 hr and Cmax 800 +/- 76 ng/ml. For total radioactivity in blood the values were Tmax 1.05 +/- 0.08 hr and Cmax 1,580 +/- 90 ng/ml (as captopril equivalents). Because of the curvilinearity of the semilogarithmic plots of blood concentrations of captopril:time, elimination half-life (t1/2) of unchanged drug could not be determined. At 1 hr unchanged captopril accounted for about 52% of total radioactivity in blood, and the dimeric disulfide metabolite of captopril accounted for about 10%. In the first 5 days after dosing, an average of about 68% of the radioactive dose was recovered in urine and 18% in feces. The distribution of radioactivity in the first 24-hr urine sample (66% of the dose) was 58% captopril (38% of dose), 2% captopril disulfide (1.5% of dose), and 40% unidentified polar metabolites (26% of dose).